Literature DB >> 11272029

The rational use of antibiotics in the treatment of brain abscess.

.   

Abstract

The Working Party was instituted to investigate the rationale of therapeutic antibiotic usage in patients with brain abscess and to make recommendations for current practice. A systematic review of English language publications on brain abscess over the last 25 years was carried out using electronic databases and secondary sources, and data were evaluated. Few publications were identified where the microbiological procedures were adequately described and many authors continue to report sterile pus in a proportion of cases. The vast majority of reports were retrospective neurosurgical assessments in which details of laboratory procedures and antibiotic regimens were missing. There are no published reports of controlled clinical trials or comparative therapeutic studies. The recommendations made by the Working Party are based on relevant published information and the expertise of Working Party members. Recommendations vary according to the location of the abscess which reflects the likely source of the infection and therefore the bacterial types most likely to be present in aspirated pus. Bacteria with multiple resistance to antimicrobial agents do not feature significantly in cases of brain abscess.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11272029     DOI: 10.1080/02688690020005527

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  22 in total

1.  Efficacy and safety of cefotaxime in combination with metronidazole for empirical treatment of brain abscess in clinical practice: a retrospective study of 66 consecutive cases.

Authors:  A-K Jansson; P Enblad; J Sjölin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-11       Impact factor: 3.267

2.  Complications of acute frontal sinusitis: a retrospective study.

Authors:  Christian S Betz; Wolfgang Issing; Johannes Matschke; Anne Kremer; Eberhard Uhl; Andreas Leunig
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-04       Impact factor: 2.503

Review 3.  Antibiotics for brain abscesses in people with cyanotic congenital heart disease.

Authors:  Pagakrong Lumbiganon; Arnkisa Chaikitpinyo
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

Review 4.  Retrospective analysis of 49 cases of brain abscess and review of the literature.

Authors:  J Carpenter; S Stapleton; R Holliman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-01       Impact factor: 3.267

5.  Pyogenic brain abscess and subdural empyema: presentation, management, and factors predicting outcome.

Authors:  John D Widdrington; Helena Bond; Ulrich Schwab; D Ashley Price; Matthias L Schmid; Brendan McCarron; David R Chadwick; Manjusha Narayanan; John Williams; Edmund Ong
Journal:  Infection       Date:  2018-07-27       Impact factor: 3.553

6.  Intracranial abscesses: changes in epidemiology and management over five decades in Merseyside.

Authors:  R Sharma; K Mohandas; R P D Cooke
Journal:  Infection       Date:  2009-01-12       Impact factor: 3.553

7.  Pediatric focal intracranial suppuration: a UK single-center experience.

Authors:  Theresa S Cole; Marcia E Clark; Alistair J Jenkins; Julia E Clark
Journal:  Childs Nerv Syst       Date:  2012-08-05       Impact factor: 1.475

Review 8.  Complications of acute otitis media in children.

Authors:  Kimmo Leskinen
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.919

9.  Braın abscess due to Streptococcus intermedius secondary to mastoiditis in a child.

Authors:  Nurhayat Yakut; Eda Kepenekli Kadayifci; Ayse Karaaslan; Serkan Atici; Gulsen Akkoc; Sevliya Ocal Demir; Adnan Dagcinar; Fatih Akbulut; Ahmet Soysal; Mustafa Bakır
Journal:  Springerplus       Date:  2015-12-23

10.  Pyogenic brain abscess, a 15 year survey.

Authors:  Jannik Helweg-Larsen; Arnar Astradsson; Humeira Richhall; Jesper Erdal; Alex Laursen; Jannick Brennum
Journal:  BMC Infect Dis       Date:  2012-11-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.